Oltolina Francesca, Gregoletto Luca, Colangelo Donato, Gómez-Morales Jaime, Delgado-López José Manuel, Prat Maria
Dipartimento di Scienze della Salute, Università del Piemonte Orientale "Amedeo Avogadro" , Via Solaroli 17, 28100 Novara, Italy.
Langmuir. 2015 Feb 10;31(5):1766-75. doi: 10.1021/la503747s. Epub 2015 Jan 30.
Multifunctional biomimetic nanoparticles (NPs) are acquiring increasing interest as carriers in medicine and basic research since they can efficiently combine labels for subsequent tracking, moieties for specific cell targeting, and bioactive molecules, e.g., drugs. In particular, because of their easy synthesis, low cost, good biocompatibility, high resorbability, easy surface functionalization, and pH-dependent solubility, nanocrystalline apatites are promising candidates as nanocarriers. This work describes the synthesis and characterization of bioinspired apatite nanoparticles to be used as fluorescent nanocarriers targeted against the Met/hepatocyte growth factor receptor, which is considered a tumor associated cell surface marker of many cancers. To this aim the nanoparticles have been labeled with Fluorescein-5-isothiocyanate (FITC) by simple isothermal adsorption, in the absence of organic, possibly toxic, molecules, and then functionalized with a monoclonal antibody (mAb) directed against such a receptor. Direct labeling of the nanoparticles allowed tracking the moieties with spatiotemporal resolution and thus following their interaction with cells, expressing or not the targeted receptor, as well as their fate in vitro. Cytofluorometry and confocal microscopy experiments showed that the functionalized nanocarriers, which emitted a strong fluorescent signal, were rapidly and specifically internalized in cells expressing the receptor. Indeed, we found that, once inside the cells expressing the receptor, mAb-functionalized FITC nanoparticles partially dissociated in their two components, with some mAbs being recycled to the cell surface and the FITC-labeled nanoparticles remaining in the cytosol. This work thus shows that FITC-labeled nanoapatites are very promising probes for targeted cell imaging applications.
多功能仿生纳米颗粒(NPs)作为医学和基础研究中的载体正越来越受到关注,因为它们可以有效地将用于后续追踪的标记物、用于特定细胞靶向的部分以及生物活性分子(如药物)结合起来。特别是,由于其易于合成、成本低、生物相容性好、高再吸收性、易于表面功能化以及pH依赖性溶解性,纳米晶磷灰石是很有前途的纳米载体候选物。这项工作描述了用作针对Met/肝细胞生长因子受体的荧光纳米载体的仿生磷灰石纳米颗粒的合成与表征,该受体被认为是许多癌症的肿瘤相关细胞表面标志物。为此,通过简单的等温吸附,在不存在可能有毒的有机分子的情况下,用异硫氰酸荧光素(FITC)标记纳米颗粒,然后用针对该受体的单克隆抗体(mAb)进行功能化。纳米颗粒的直接标记允许以时空分辨率追踪这些部分,从而跟踪它们与表达或不表达靶向受体的细胞的相互作用,以及它们在体外的命运。细胞荧光测定法和共聚焦显微镜实验表明,发出强荧光信号的功能化纳米载体在表达该受体的细胞中被快速且特异性地内化。实际上,我们发现,一旦进入表达受体的细胞内,mAb功能化的FITC纳米颗粒会部分解离成其两个组分,一些mAb会循环回到细胞表面,而FITC标记的纳米颗粒则留在细胞质中。因此,这项工作表明FITC标记的纳米磷灰石是用于靶向细胞成像应用的非常有前途的探针。